CTLA-4: From conflict to clinic

被引：11
|
作者：
不详
机构：
来源：
JOURNAL OF EXPERIMENTAL MEDICINE | 2007年 / 204卷 / 06期
关键词：
D O I：
10.1084/jem.2046fta
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
CTLA-4 was first identified in 1991 as a second receptor for the T cell costimulation ligand B7. Uncertainties about its biological function plagued the early years after its discovery until 1995, when it was confirmed to be an inhibitor of T cell responses. CTLA-4 has since scored in the clinic as a target for antitumor therapy and as a soluble inhibitor of autoimmunity.
引用
收藏
页码：1243 / 1243
页数：1
相关论文
共 50 条
  • [21] CTLA-4 blockade: Autoimmunity as treatment
    Kapadia, D
    Fong, L
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (35) : 8926 - 8928
  • [22] A molecular perspective of CTLA-4 function
    Teft, Wendy A.
    Kirchhof, Mark G.
    Madrenas, Joaquin
    ANNUAL REVIEW OF IMMUNOLOGY, 2006, 24 : 65 - 97
  • [23] The role of CTLA-4 in Treg function
    Qureshi, O. S.
    Zheng, Y.
    Manzotti, C. N.
    Walker, L. S. K.
    Sansom, D. M.
    IMMUNOLOGY, 2008, 125 : 64 - 64
  • [24] New inhibitory signaling by CTLA-4
    Christoph Wülfing
    Helen M Tunbridge
    David C Wraith
    Nature Immunology, 2014, 15 : 408 - 409
  • [25] CTLA-4: a key protein in autoimmunity
    Jagadeesh Bayry
    Nature Reviews Rheumatology, 2009, 5 : 244 - 245
  • [26] CTLA-4: a key protein in autoimmunity
    Bayry, Jagadeesh
    NATURE REVIEWS RHEUMATOLOGY, 2009, 5 (05) : 244 - 245
  • [27] Molecular and Cellular Functions of CTLA-4
    Van Coillie, Samya
    Wiernicki, Bartosz
    Xu, Jie
    REGULATION OF CANCER IMMUNE CHECKPOINTS: MOLECULAR AND CELLULAR MECHANISMS AND THERAPY, 2020, 1248 : 7 - 32
  • [28] Regulation of systemic autoimmunity by CTLA-4
    Chuang, E
    Zhou, L
    Yi, A
    Elkon, K
    FASEB JOURNAL, 2001, 15 (04): : A343 - A343
  • [29] Expression of CTLA-4 by human monocytes
    Wang, XB
    Giscombe, R
    Yan, Z
    Heiden, T
    Xu, D
    Lefvert, AK
    SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 2002, 55 (01) : 53 - 60
  • [30] Polymorphsims of CTLA-4 Exon 1 +49, CTLA-4 Promoter –318 and Fas Promoter –670 in Spondyloarthropathies
    Y. H. Lee
    J. D. Ji
    J. Sohn
    G. G. Song
    Clinical Rheumatology, 2001, 20 : 420 - 422
12345